Clinical Trial: A Study to Investigate the Pharmacokinetics of AZD2389 When Administered Alone and in Combination With Itraconazole in Healthy Participants

U.S., Feb. 27 -- ClinicalTrials.gov registry received information related to the study (NCT06846528) titled 'A Study to Investigate the Pharmacokinetics of AZD2389 When Administered Alone and in Combination With Itraconazole in Healthy Participants' on Feb. 21.

Brief Summary: The purpose of this study is to assess the pharmacokinetics (PK) of AZD2389 when administered alone and in combination with itraconazole in healthy participants.

Study Start Date: Feb. 26

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: AZD2389

AZD2389 is administered orally

DRUG: Itraconazole

Itraconazole is administered orally

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca

Disclaimer: Curated by HT Syndication....